your market intelligence analyst
Search Results
Edit Save
2,037 results 02/27/2020 21:27
From global economic concerns and escalating trade tensions to the ‘closed border mentality’ being adopted by some nation states, as we enter the new decade, there’s a real sense that the era of fervent globalisation and the pursuit of ever-more frictionless trade may now be at an end. Whatever happens next, however, it’s clear that digitisation has forever changed the face of business. 02/25/2020 00:14
Do medical device manufacturers bring new advantages to labelling compliance thanks to their engineering-orientated approach? asks Kallik’s David Bennett. In the pharmaceutical world, labelling change management is a complex enough affair already. But it’s made all the more challenging because the physical labelling side tends to be handled by regulatory and manufacturing teams, while the artwork by design teams is typically managed at third-party agencies. None of this is well coordinated and... 02/24/2020 00:02
Fake pharmaceuticals are on the rise and are readily available online, with Search Engines pivotal in directing users to infringing locations. To uncover the scale of the issue, Incopro undertook new research into the role Search Engines play in serving counterfeit and other illegal content to unwitting consumers.Search Engines are enabling illegal online pharmacies to flourish, and this puts consumers at great risk. Search engines should provide a scalable solution to help brands remove ille... 02/19/2020 23:01
This year, around 200,000 people in the UK – roughly one every three minutes – will be diagnosed with Type 2 diabetes (T2D). For many, it will be a daunting prospect; the condition can lead to long-term complications such as sight loss, amputation or kidney failure, as well as increasing the risk of heart attack or stroke. However, while the potential implications of diabetes are well documented, the disease is commonly misunderstood. A high percentage of people think that T2D is untreatable... 02/04/2020 22:45
By Sharon Rindsland, Senior Manual Handling Co-ordinator, East Kent Hospitals. Since 1975 worldwide obesity has nearly tripled. In 2016, more than 1.9 billion adults were classed as being overweight, of these 650 million were obese. However, this doesn’t just apply to adults, over 340 million children and adolescents aged 5-19 were overweight or obese in 2016 . Unfortunately, complications related to obesity continue post-mortem. Nursing staff and mortuary technicians often face these complica... 01/30/2020 05:36
Manchester, UK, 30th January 2020 – Chiesi, an international research-focussed pharmaceutical group (Chiesi Group), has been awarded the exclusive Top Employers UK and the Top Employers Europe for the eighth consecutive year running following an extensive review process by the Top Employers Institute. The Top Employers Institute recognises excellence in people and working practices, through analysing data and information relating to the Human Resource management policies of global companies.... 01/20/2020 07:16
Fasenra being evaluated in eight eosinophil-driven diseases beyond severe asthma. AstraZeneca today announced three new trials for Fasenra (benralizumab) in skin diseases, adding to five trials already underway for the medicine in eosinophil-driven diseases (EDDs) beyond severe asthma. In EDD, immune system dysfunction causes eosinophil recruitment and activation leading to chronic local and/or systemic inflammation.1. The three new trials for Fasenra in skin diseases include two Phase II trial... 01/15/2020 22:39
As life sciences firms continue invest in collating comprehensive regulated product data for compliance purposes, could they be doing more to capitalise on the insights locked within these rich digital resources. AMPLEXOR’s David Gwyn considers the untapped potential. Having digitalised and centralised all of its regulated product data, a major global pharmaceutical company recently realised that it now has unprecedented insight into the relative regulatory and market status of all of its pro... 01/15/2020 05:57
Switzerland, January 15th 2020 – Oviva, the leading digital provider of Type 2 diabetes treatment in Europe, has raised $21m in Series B funding. MTIP led the round, joined by Earlybird as new investors. Existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech all participated. The new capital will be used to further develop Oviva’s technology and expand in Europe to serve the millions of patients not accessing treatment today. It brings the total amount raised by Oviva... 01/13/2020 22:09
BIOGEN TO ACQUIRE NOVEL CLINICAL STAGE ASSET WITH APPLICATION IN ALZHEIMER’S DISEASE AND PARKINSON’S DISEASE FROM PFIZER INC. PF-05251749 is a CNS-penetrant regulator of circadian rhythm with potential to address behavioral and neurological symptoms across various psychiatric and neurological diseases. Biogen to pay Pfizer $75 million upfront plus potential milestones of up to $635 million, and royalties. PF-05251749 complements the Company’s pipeline of potential disease-modifying... 01/13/2020 21:10
If escalating salaries are unsustainable, what else can life sciences firms do to retain valuable pharmacovigilance talent as shortages grow, asks Alan White, CEO of Arriello. There has been much talk recently about the challenge of retaining talent in life sciences, particularly in relation to safety and regulatory disciplines, where younger professionals’ ambitions for a broad base of experience are jarring with companies’ needs to hold onto expertise they have invested in. The issue appea... 01/13/2020 20:41
MONACO, PRINCIPALITY OF MONACO, AND NEW YORK, NY, USA, January 14, 2020: Lyfebulb, a patient empowerment platform that connects patients with industry to support user-driven innovation toward solutions in chronic disease, and Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, announce the 11 Patient Entrepreneurs chosen as finalists for the Lyfebulb-Helsinn Cancer Innovation Summit & Award to be held on January 30, 2020. 01/13/2020 05:03
Catalysis. Enzymes are a class of biological catalysts. They govern many catalytic processes such as metabolism, nutrition, and energy conversion of organisms. Most of the reactions closely related to life processes are enzyme-catalyzed reactions. These properties of the enzyme enable the intricate process of material metabolism in the cell to proceed in an orderly manner, and to adapt material metabolism to normal physiological functions. If an enzyme is defective due to genetic defects, or... 01/08/2020 22:22
Newcastle University is investing £280,000 with Arrayjet, the UK’s leading provider of microarray instrumentation technology, as part of its plan to establish a pioneering microarray centre for the northern half of the United Kingdom. The centre will be used by other university departments, as well as external life science and biotechnology research partners. The funding for the new centre was secured through the Biotechnology and Biological Sciences Research Council (BBSRC) 18ALERT fund.&nbs... 01/08/2020 04:09
Almirall has an option right to acquire Bioniz Therapeutics, Inc. which will give full global rights to BNZ-1. BNZ-1 is a multicytokine inhibitor that selectively blocks the activity of three cytokines of the same family: IL-2, IL-9 and IL1-15, currently in phase 1/2 development for refractory Cutaneous T-cell Lymphoma. If Almirall exercises the option, it will also enter into a broader research agreement with Bioniz NewCo, using its multiple cytokine inhibitor platform with the objective to d... 01/01/2020 22:48
Exercise and aging. Although lots of money and efforts have been invested into drug development, no drug is found to be effective in combatting aging. It is important to note that exercise is a truly effective anti-aging measure. In the absence of suitable treatments for age-related dysfunction, exercise is currently the only intervention that shows significant efficacy, reducing the incidence of age-related diseases, improving quality of life, and even increasing the life expectancy of the hu... 12/26/2019 01:38
Smart medical devices refers to the electrical devices that have an autonomous processing system within them and are used to monitor a range of health and fitness parameters on an everyday basis. These devices provide a multitude of advantages to the patient and caregiver in monitoring and measuring various healthcare regimens such as sensing the lowered levels of insulin through artificial intelligence among type 1 diabetes patients and delivering insulin. Smart medical devices have radicall... 12/23/2019 04:11
PARIS – December 23, 2019 – Sanofi announced today that it intends to commence a tender offer (the "Offer") today to acquire all of the outstanding shares of common stock of Synthorx, Inc. ("Synthorx") for $68 per share in cash, without interest thereon and net of any applicable withholding taxes. The Offer is being made pursuant to the Agreement and Plan of Merger, dated as of December 7, 2019 (as it may be amended from time to time, the "Merger Agreement"), by and among Synthorx, Sanofi an...

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications